LDC wins Private Equity Investor of the Year at the HealthInvestor Awards 2025

LDC was named Private Equity Investor of the Year at the HealthInvestor Awards last night.

The awards, held at the Grosvenor House Hotel in London, recognise achievement and success across the health and social care sectors.

During the qualifying period, LDC completed three transactions in healthcare bringing its total invested in the sector over the last decade to over £400 million, with a combined enterprise value on entry of over £900m.

The judges praised LDC’s investments in multiple new platforms in 2024 as well as providing further capital to its existing portfolio companies, demonstrating once again its sector commitment and its expansive & diverse investment approach.

LDC invested in Medray Group, a leading provider of diagnostic imaging equipment in July 2024, and in Bullen Healthcare, the UK’s largest independent dispensing appliance contractor of stoma, urology and wound care products in September 2024, to support the next phase of their ambitious growth strategies. It also supported portfolio company Connect Health’s merger with Healthshare, another specialist healthcare provider.

Alongside transactions, LDC continued to support the growth of its healthcare portfolio companies, including Ashtons Hospital Pharmacy Services securing a new five-year contract with Priory, and Duncan & Todd, the largest privately-owned optician and hearing care chain in Scotland, investing around £1.5m in a new ‘state-of-the-art’ lens manufacturing laboratory, tripling its capacity.

LDC also helped EMS Healthcare and Kingswood Mobility Group to accelerate the integration of ESG ambitions in their business strategies.

LDC continued to grow and develop the LDC Healthcare Leaders Network, which provides some of the UK’s most exciting and fastest-growing healthcare businesses the opportunity to come together to discuss the opportunities and challenges they are facing.

LDC extends its congratulations to all of the companies and individuals that won awards or were shortlisted at the HealthInvestor Awards 2025, including our portfolio company RDi which was shortlisted in the Diagnostics Provider of the Year category. You can view the full list of winners here.